Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912.

ABSTRACT:

SUBMITTER: Shanafelt TD 

PROVIDER: S-EPMC11788128 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature